{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:39:50Z","timestamp":1778657990234,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.cyto.2009.11.014","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T09:45:40Z","timestamp":1263980740000},"page":"279-286","source":"Crossref","is-referenced-by-count":10,"title":["High glucose and interleukin-1\u03b2 downregulate interleukin-1 type I receptor (IL-1RI) in retinal endothelial cells by enhancing its degradation by a lysosome-dependent mechanism"],"prefix":"10.1016","volume":"49","author":[{"given":"C\u00e9lia","family":"Aveleira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1urea","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermelindo","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio Francisco","family":"Ambr\u00f3sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2009.11.014_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000027528","article-title":"Diabetic retinopathy: surrogate outcomes for drug development for diabetic retinopathy","volume":"214","author":"Cunha-Vaz","year":"2000","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.cyto.2009.11.014_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/diacare.21.1.143","article-title":"Diabetic retinopathy","volume":"21","author":"Aiello","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2009.11.014_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0014-4835(03)00213-6","article-title":"The blood-retinal barriers system. Basic concepts and clinical evaluation","volume":"78","author":"Cunha-Vaz","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cyto.2009.11.014_bib4","doi-asserted-by":"crossref","unstructured":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med 1993;329:977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.cyto.2009.11.014_bib5","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2009.11.014_bib6","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1167\/iovs.07-0112","article-title":"Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy","volume":"48","author":"Leal","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2337\/diabetes.47.12.1953","article-title":"Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn state retina research group","volume":"47","author":"Antonetti","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2009.11.014_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/exer.1998.0546","article-title":"Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes","volume":"67","author":"Carmo","year":"1998","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cyto.2009.11.014_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina","volume":"158","author":"Joussen","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2009.11.014_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9394(14)74052-8","article-title":"Cytokines in the vitreous of patients with proliferative diabetic retinopathy","volume":"114","author":"Abu el Asrar","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.cyto.2009.11.014_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1056-8727(01)00155-6","article-title":"Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy","volume":"15","author":"Yuuki","year":"2001","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.cyto.2009.11.014_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.eye.6702138","article-title":"Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy","volume":"20","author":"Demircan","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.cyto.2009.11.014_bib13","first-page":"3047","article-title":"In vivo retinal gene expression in early diabetes","volume":"42","author":"Joussen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib14","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1016\/S0042-6989(99)00117-0","article-title":"L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity","volume":"39","author":"Carmo","year":"1999","journal-title":"Vision Res"},{"key":"10.1016\/j.cyto.2009.11.014_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1167\/iovs.04-0860","article-title":"Expression of acute-phase response proteins in retinal Muller cells in diabetes","volume":"46","author":"Gerhardinger","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib16","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1167\/iovs.04-0633","article-title":"Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants","volume":"45","author":"Kowluru","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2009.11.014_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression","volume":"16","author":"Joussen","year":"2002","journal-title":"Faseb J"},{"key":"10.1016\/j.cyto.2009.11.014_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/09629350020025764","article-title":"Effect of cyclosporin-A on the blood\u2013retinal barrier permeability in streptozotocin-induced diabetes","volume":"9","author":"Carmo","year":"2000","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.cyto.2009.11.014_bib20","first-page":"25","article-title":"Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina","volume":"38","author":"Bamforth","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0166-2236(00)01661-1","article-title":"Interleukin 1 in the brain: biology, pathology and therapeutic target","volume":"23","author":"Rothwell","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.cyto.2009.11.014_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-5728(92)90257-L","article-title":"Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein","volume":"39","author":"Sparacio","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib23","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.144.8.2999","article-title":"Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta","volume":"144","author":"Chung","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.183.1.311","article-title":"Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice","volume":"183","author":"Chai","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.11.014_bib25","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.90.13.6155","article-title":"Interleukin 1 signaling occurs exclusively via the type I receptor","volume":"90","author":"Sims","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2009.11.014_bib26","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.4049\/jimmunol.161.10.5614","article-title":"IL-1 receptor accessory protein is an essential component of the IL-1 receptor","volume":"161","author":"Cullinan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.162.2.501","article-title":"Detection and characterization of high affinity plasma membrane receptors for human interleukin 1","volume":"162","author":"Dower","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.11.014_bib28","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4049\/jimmunol.138.9.2906","article-title":"The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts","volume":"138","author":"Mizel","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood.V78.5.1262.1262","article-title":"Endothelial cells express the interleukin-1 receptor type I","volume":"78","author":"Boraschi","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2009.11.014_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4049\/jimmunol.139.4.1173","article-title":"Recombinant murine and human IL 1 alpha bind to human endothelial cells with an equal affinity, but have an unequal ability to induce endothelial cell adherence of lymphocytes","volume":"139","author":"Thieme","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cne.20052","article-title":"Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli","volume":"472","author":"Konsman","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.cyto.2009.11.014_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0167-5699(97)81662-3","article-title":"Cytokine regulation of endothelial cell function: from molecular level to the bedside","volume":"18","author":"Mantovani","year":"1997","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2009.11.014_bib33","first-page":"159","article-title":"Activation and injury of endothelial cells by cytokines","volume":"46","author":"Pober","year":"1998","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.cyto.2009.11.014_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exer.2000.0941","article-title":"Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat","volume":"72","author":"Hosoya","year":"2001","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cyto.2009.11.014_bib35","doi-asserted-by":"crossref","first-page":"34878","DOI":"10.1074\/jbc.M501977200","article-title":"Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines","volume":"280","author":"Levrand","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2009.11.014_bib36","first-page":"311","article-title":"Internalization and nuclear localization of interleukin 1 are not sufficient for function","volume":"2","author":"Heguy","year":"1991","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.cyto.2009.11.014_bib37","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1016\/S0021-9258(18)68472-8","article-title":"Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts","volume":"263","author":"Qwarnstrom","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2009.11.014_bib38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjo.2003.038133","article-title":"Role of interleukin-1beta in the pathogenesis of diabetic retinopathy","volume":"88","author":"Kowluru","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cyto.2009.11.014_bib39","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.274.5290.1194","article-title":"Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors","volume":"274","author":"Rosette","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cyto.2009.11.014_bib40","first-page":"427","article-title":"Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression","volume":"75","author":"Ye","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2009.11.014_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/cimm.1996.0076","article-title":"The effect of cytokine stimulation on IL-1 receptor mRNA expression by intestinal epithelial cells","volume":"168","author":"McGee","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib42","first-page":"213","article-title":"Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis","volume":"13","author":"Takii","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1016\/j.cyto.2009.11.014_bib43","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2009.11.014_bib44","first-page":"539","article-title":"Interleukin-1 receptors","volume":"5","author":"Sims","year":"1994","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cyto.2009.11.014_bib45","first-page":"1971","article-title":"Glial reactivity, an early feature of diabetic retinopathy","volume":"41","author":"Rungger-Brandle","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cyto.2009.11.014_bib46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0952523800173122","article-title":"Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats","volume":"17","author":"Zeng","year":"2000","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.cyto.2009.11.014_bib47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.144.4.1295","article-title":"IL-1 and its receptor are translocated to the nucleus","volume":"144","author":"Curtis","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.11.014_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/db06-0427","article-title":"Inhibition of caspase-1\/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia","volume":"56","author":"Vincent","year":"2007","journal-title":"Diabetes"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466609008758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466609008758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T17:47:42Z","timestamp":1685382462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466609008758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1043466609008758"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2009.11.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}